Namyang Dairy is in trouble after a number of furious investors have called for a boycott. They urged the consumers to stop buying the company’s products.
Namyang’s COVID-19 claim
The root cause of this action from the investors was Namyang Dairy’s claim that its Bulgaris yogurt drink can help fight the symptoms of COVID-19. Last week, the South Korean food and dairy company said that its stock price increased by more than eight percent on April 13 and continued to go up to over 28% the next day.
At that time, it was reported that Namyang’s share surge was caused by the consumers’ rush to buy its Bulgaris yogurt after it released a statement saying that the product can prevent COVID-19. However, health officials are questioning the company’s claims and suggested that they are false and have no scientific basis.
The controversial claim was announced during a symposium hosted by the Korea Research & Institute of BioMedical last week. At the event, Namyang’s internal research institute presented the results of its research on Yogurt drink called Bulgaris, as per The Korea Herald.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Company’s representative, Park Jong Su, said at the symposium. “Our experiments showed that Bulgaris helped remove the influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
S. Korea’s food and drug ministry reacts
The experts from the Ministry of Food and Drug Safety and Korea Disease Control and Prevention Agency immediately questioned Namyang’s statements about its Bulgaris yogurt. They are asking about the effectiveness claim against COVID-19 and they concluded that the dairy firm exaggerated the research results that it released in the previous symposium.
The Korea Times reported that because of this, the investors are now taking action against Namyang. They are using social media to ask the public to join in their calls to boycott the company’s products. Apparently, they are angry not just due to the coronavirus statements but also because they believe Namyang lied to manipulate the stock price.
Meanwhile, amid the backlash from the public and health experts, Namyang Dairy issued an apology for the confusion. "We apologize to our customers for causing misunderstanding with our research results,” a company official stated. “The test was not based on human testing, but at the cellular stage, from which we couldn't have concluded its effectiveness against COVID-19."


Wall Street Faces Inflation Pressure as Strong Earnings Season Nears End
U.S.-Iran Talks Advance as Trump Signals Tough Stance on Hormuz and Nuclear Deal
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid
Wall Street Futures Rally as Oil Prices Drop Amid Optimism Over U.S.-Iran Talks
OpenAI Expands Globally with First Overseas AI Lab in Singapore
Oil Prices Drop Below $100 as U.S.-Iran Talks Ease Strait of Hormuz Fears
ECB Signals Possible Rate Hike as Iran Conflict Fuels Inflation Concerns
Google Expands AI Partnership With Singapore Government
Singapore Economy Grows 6% in Q1 2026 Despite Rising Middle East Risks
European Airline Stocks Rise as Oil Prices Drop on U.S.-Iran Strait of Hormuz Deal Hopes
Gold Prices Surge as U.S.-Iran Peace Deal Hopes Boost Market Sentiment
Trump-China Summit Yields Limited Progress on Trade and Tech Cooperation
Mexico-EU Free Trade Deal Signals Strategic Shift Away From U.S. Dependence
SpaceX Starship V3 Test Flight Boosts IPO Momentum Ahead of Historic Market Debut
Dollar Weakens as Iran Peace Deal Hopes Boost Global Market Sentiment
World Bank Emergency Funding Demand Surges as 27 Countries Seek Crisis Support Amid Iran Conflict
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO 



